171 related articles for article (PubMed ID: 31750328)
21. Stressful life-events, anxiety, depression and coping in patients of irritable bowel syndrome.
Pinto C; Lele MV; Joglekar AS; Panwar VS; Dhavale HS
J Assoc Physicians India; 2000 Jun; 48(6):589-93. PubMed ID: 11273536
[TBL] [Abstract][Full Text] [Related]
22. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial.
Jang AL; Hwang SK; Kim DU
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):918-26. PubMed ID: 24999797
[TBL] [Abstract][Full Text] [Related]
23. Different associations of health related quality of life with pain, psychological distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder.
Seres G; Kovács Z; Kovács A; Kerékgyártó O; Sárdi K; Demeter P; Mészáros E; Túry F
J Clin Psychol Med Settings; 2008 Dec; 15(4):287-95. PubMed ID: 19104985
[TBL] [Abstract][Full Text] [Related]
24. [
Sun YZ; Wang SL; Yu TY
Zhongguo Zhen Jiu; 2021 Jan; 41(1):13-6. PubMed ID: 33559435
[TBL] [Abstract][Full Text] [Related]
25. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
Lackner JM; Jaccard J; Keefer L; Brenner DM; Firth RS; Gudleski GD; Hamilton FA; Katz LA; Krasner SS; Ma CX; Radziwon CD; Sitrin MD
Gastroenterology; 2018 Jul; 155(1):47-57. PubMed ID: 29702118
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial.
Khalighi Sikaroudi M; Mokhtare M; Janani L; Faghihi Kashani AH; Masoodi M; Agah S; Abbaspour N; Dehnad A; Shidfar F
Complement Med Res; 2020; 27(5):302-309. PubMed ID: 32203968
[TBL] [Abstract][Full Text] [Related]
27. Psychological Interventions for Irritable Bowel Syndrome.
Surdea-Blaga T; Baban A; Nedelcu L; Dumitrascu DL
J Gastrointestin Liver Dis; 2016 Sep; 25(3):359-66. PubMed ID: 27689201
[TBL] [Abstract][Full Text] [Related]
28. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
29. Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ).
Ebrahimi A; Forghani M; Bababkhanian M; Ebrahimi M; Adibi Sedeh P
Gastroenterol Hepatol Bed Bench; 2023; 16(3):326-335. PubMed ID: 37767317
[TBL] [Abstract][Full Text] [Related]
30. Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/support.
Lackner JM; Gudleski GD; Radziwon CD; Krasner SS; Firth RS; Naliboff BD; Vargovich AM; Borden AB; Mayer EA
Behav Res Ther; 2022 Jul; 154():104033. PubMed ID: 35653934
[TBL] [Abstract][Full Text] [Related]
31. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
[TBL] [Abstract][Full Text] [Related]
32. Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome.
Guo J; Lu G; Chen L; Geng H; Wu X; Chen H; Li Y; Yuan M; Sun J; Pei L
Acupunct Med; 2022 Feb; 40(1):34-42. PubMed ID: 34231397
[TBL] [Abstract][Full Text] [Related]
33. [Mind-regulating and spleen-strengthening needling technique improves abdominal hypersensitivity and emotion by enhancing functional connectivity between hippocampus and brain regions in diarrhea-predominant irritable bowel syndrome patients].
Geng H; Weng SJ; Zhao TT; Chen L; Wu XL; Zhou JL; Sun JH; Pei LX
Zhen Ci Yan Jiu; 2021 Apr; 46(4):318-25. PubMed ID: 33931998
[TBL] [Abstract][Full Text] [Related]
34. The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.
Dehkordi AH; Solati K
J Adv Pharm Technol Res; 2017; 8(2):67-72. PubMed ID: 28516059
[TBL] [Abstract][Full Text] [Related]
35. The Effects of Cognitive Behavioral Therapy for Insomnia among College Students with Irritable Bowel Syndrome: A Randomized Controlled Trial.
Yang YY; Jun S
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36361052
[TBL] [Abstract][Full Text] [Related]
36. Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome.
Sugaya N; Nomura S
Biopsychosoc Med; 2008 Apr; 2():9. PubMed ID: 18394202
[TBL] [Abstract][Full Text] [Related]
37. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
Bafutto M; Almeida JR; Leite NV; Costa MB; Oliveira EC; Resende-Filho J
Arq Gastroenterol; 2013; 50(4):304-9. PubMed ID: 24474234
[TBL] [Abstract][Full Text] [Related]
38. Pain Catastrophizing and Clinical Outcomes Among Patients Receiving a Novel Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: An Experimental Therapeutics Approach.
Roger AH; Gudleski GD; Quigley BM; Zvolensky MJ; Lackner JM
Behav Ther; 2023 Jul; 54(4):623-636. PubMed ID: 37330253
[TBL] [Abstract][Full Text] [Related]
39. Clinical efficacy of cognitive behavioral therapy combined with pinaverium bromide tablets on irritable bowel syndrome.
Liu Q; Zhu Y; Wang W; Dong Y
Pak J Med Sci; 2023; 39(4):1013-1017. PubMed ID: 37492283
[TBL] [Abstract][Full Text] [Related]
40. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.
Lackner JM; Jaccard J; Krasner SS; Katz LA; Gudleski GD; Holroyd K
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):899-906. PubMed ID: 18524691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
